China National Accord Medicines Corp Ltd Cash Flow Quality Index
China National Accord Medicines Corp Ltd cash flow quality index. China National Accord Medicines Corp Ltd (000028) has a Cash Flow Quality Index of -1.46x as of September 2025. Operating cash flow of CN¥-425.23 Million is below net income of CN¥291.21 Million, suggesting accrual-heavy earnings not yet converted to cash. See China National Accord Medicines Corp Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China National Accord Medicines Corp Ltd (1998–2024)
Cash flow quality index of China National Accord Medicines Corp Ltd from 1998 to 2024. Historical Cash Flow Quality Index for China National Accord Medicines Corp Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore China National Accord Medicines Corp Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
China National Accord Medicines Corp Ltd Cash Flow Quality Index by Year (1998–2024)
China National Accord Medicines Corp Ltd cash flow quality index by year from 1998 to 2024. Year-by-year earnings quality comparison for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see China National Accord Medicines Corp Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 13.80x | CN¥3.27 Billion | CN¥237.00 Million | ▲ +651.6% |
| 2023 | 1.84x | CN¥2.94 Billion | CN¥1.60 Billion | ▲ +27.1% |
| 2022 | 1.45x | CN¥2.56 Billion | CN¥1.77 Billion | ▲ +33.4% |
| 2021 | 1.08x | CN¥1.66 Billion | CN¥1.53 Billion | ▲ +24.1% |
| 2020 | 0.87x | CN¥1.50 Billion | CN¥1.72 Billion | ▼ -35.2% |
| 2019 | 1.35x | CN¥2.00 Billion | CN¥1.48 Billion | ▲ +37.4% |
| 2018 | 0.98x | CN¥1.32 Billion | CN¥1.35 Billion | ▼ -11.7% |
| 2017 | 1.11x | CN¥1.29 Billion | CN¥1.16 Billion | ▼ -3.3% |
| 2016 | 1.15x | CN¥1.47 Billion | CN¥1.28 Billion | ▼ -13.7% |
| 2015 | 1.33x | CN¥1.05 Billion | CN¥787.35 Million | ▲ +211.9% |
| 2014 | -1.19x | CN¥-796.70 Million | CN¥669.84 Million | ▼ -236.6% |
| 2013 | 0.87x | CN¥465.03 Million | CN¥534.22 Million | ▲ +30.0% |
| 2012 | 0.67x | CN¥323.96 Million | CN¥483.68 Million | ▼ -3.4% |
| 2011 | 0.69x | CN¥227.32 Million | CN¥327.82 Million | ▼ -57.2% |
| 2010 | 1.62x | CN¥428.16 Million | CN¥264.22 Million | ▲ +18.6% |
| 2009 | 1.37x | CN¥270.85 Million | CN¥198.26 Million | ▼ -10.0% |
| 2008 | 1.52x | CN¥246.58 Million | CN¥162.45 Million | ▲ +116.2% |
| 2007 | 0.70x | CN¥87.70 Million | CN¥124.91 Million | ▼ -70.0% |
| 2006 | 2.34x | CN¥181.73 Million | CN¥77.76 Million | ▼ -43.6% |
| 2005 | 4.15x | CN¥148.28 Million | CN¥35.77 Million | ▼ -15.4% |
| 2004 | 4.90x | CN¥130.30 Million | CN¥26.58 Million | ▼ -8.9% |
| 2003 | 5.38x | CN¥81.22 Million | CN¥15.11 Million | ▼ -20.1% |
| 2002 | 6.73x | CN¥28.76 Million | CN¥4.28 Million | ▲ +227.3% |
| 2001 | 2.06x | CN¥71.16 Million | CN¥34.61 Million | ▲ +130.7% |
| 1999 | 0.89x | CN¥22.84 Million | CN¥25.62 Million | ▲ +141.6% |
| 1998 | 0.37x | CN¥5.21 Million | CN¥14.12 Million | — |